1.4K views · 19 shares | Dr. Adaya Weissler-Snir discusses Myotonic Dystrophy, a genetic disorder that affects movement. Gilbert Gottfried dies at the age of 67 from ventricular tachycardia caused by myotonic dystrophy type II so this condition has been heavily in the news. She explains the condition and what it effects as well as the cause of the disease. She also talks about the different types and the treatments. | Hartford HealthCare | Facebook

5.4K views | How can an RNA be used to treat myotonic dystrophy? ARTHEx biotech is focused on the development of the next generation of RNA therapies for genetic diseases. Our first product in the pipeline is a first-in-class treatment against myotonic dystrophy type 1, an orphan and rare disease. This therapy is based on an antisense oligonucleotide that inhibits the action of microRNAs (also known as antimiR). Learn more now: | Sci Ani | Facebook